Synopsis of recent research by authors named "Jae-Kyung Koo"
- Jae-Kyung Koo's research primarily focuses on the production and characterization of biopharmaceuticals, specifically recombinant proteins, utilizing systems such as CHO cells and transgenic plants.
- One significant study involved the creation of a long-acting recombinant human albumin-EPO fusion protein, highlighting the importance of albumin as a linker to enhance EPO's therapeutic effectiveness through co-transfection techniques.
- Another key finding demonstrated the efficacy of hCTLA4Ig produced in transgenic rice cell cultures, showing its potential for immunosuppressive applications, particularly in relation to cytokine modulation in T cells, indicating a promising avenue for biotechnological interventions in immune disorders.
